Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
Clinical trial NCT02521285 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02521285
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-15
- Primary completion
- 2019-06-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.